DASH-ing Through the Genome

Hybaid's Dynamic Allele Specific Hybridization system Understanding the relationship between genetic variations at the nucleotide sequence level and human disease will profoundly change prevention and treatment methods in the next decade. The DNA sequence information produced through the Human Genome Project will reveal thousands of variations at single nucleotides, termed single nucleotide polymorphisms (SNPs). Such sequence variations in DNA may disrupt gene function and be causally associated

Written byGrace Athas
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share


Hybaid's Dynamic Allele Specific Hybridization system
Understanding the relationship between genetic variations at the nucleotide sequence level and human disease will profoundly change prevention and treatment methods in the next decade. The DNA sequence information produced through the Human Genome Project will reveal thousands of variations at single nucleotides, termed single nucleotide polymorphisms (SNPs). Such sequence variations in DNA may disrupt gene function and be causally associated with human disease. In the near future, technologies for rapid, large-scale identification and/or scoring of SNPs will be used to design diagnostics and targeted therapies for disease.

Hybaid (Franklin, Mass.) released its new dedicated system for SNP detection, the DASH (Dynamic Allele Specific Hybridization) system, in July 1999. It provides a fast, sensitive method to score SNPs based on the melting temperature (denaturation) of target-probe complexes. The DASH system monitors the level of fluorescence emitted from a dye intercalated into the target-probe sequences ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies